Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FP82N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,013
Award facts
- Contract value 100% obligated
- $57,013.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,013.10 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Wegovy 1.7 mg/0.75 mL pens. This firm fixed-price contract, with a completion date of September 25, 2025, was awarded without set-aside status through competitive procedures and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, regularly fulfills federal medical procurement requirements through its extensive federal contract portfolio, particularly with the Defense Logistics Agency and its Medical Supply Chain. The company's federal awards demonstrate significant capability in delivering diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Wegovy, a GLP-1 receptor agonist medication, supports the Defense Health Agency's healthcare mission and reflects AmerisourceBergen's critical role as a primary vendor for federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FP82N?
SPE2DB25FP82N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FP82N worth?
The government has obligated $57,013 on SPE2DB25FP82N.
Is contract SPE2DB25FP82N an order under another contract?
Yes. SPE2DB25FP82N is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP82N competed?
The extent of competition for SPE2DB25FP82N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award